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Background:  
Seasonal influenza vaccination is effective in preventing influenza infection and disease 
in healthy school-age children, while influenza vaccination is not generally thought to 
affect the risk of non-influenza respiratory virus infections (e.g. the common cold). 
Interference between respiratory virus epidemics has been reported in a series of 
ecologic studies, and it has been hypothesized that this phenomenon is associated with 
temporary non-specific immunity following a respiratory viral infection.  
 
Methods: 
In November-December 2008, we conducted a randomized controlled trial and 
administered 2008-09 seasonal trivalent inactivated influenza vaccine (TIV) or placebo 
to one child aged 6-15 years in each of 115 households. Subjects were followed up for 
approximately 9 months with four serum draws, and report of acute respiratory illness 
in any household member triggered home visits for collection of pooled nose and throat 
swabs from all household members regardless of illness. Swabs were tested to confirm 
infections with 19 respiratory viruses by the ResPlex II Plus multiplex RT-PCR array, 
and with influenza A and B by RT-PCR. 
 
  
Results:  
We identified 134 episodes of acute respiratory illness with no statistically significant 
difference in incidence rates between recipients of TIV and placebo. Compared to 
placebo recipients, there was a statistically significant increased risk of confirmed non-
influenza respiratory virus infections among TIV recipients (relative risk: 4.40; 95% CI: 
1.31, 14.8), which appeared to be associated with an increased risk of rhinovirus and 
coxsackie/echovirus infections in March 2009, shortly after the winter influenza season 
in February 2009. 
 
Conclusions:  
Although they were protected against influenza, TIV recipients appeared to face a higher 
risk of non-influenza respiratory virus infections. One potential explanation is 
temporary non-specific immunity, a phenomenon that remains to be fully characterized.  
